Ellevest, Inc. Seelos Therapeutics, Inc. Transaction History

Ellevest, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$0.51 - $0.93 $129 - $236	-254 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$1.59 - $2.38 $25 - $38	-16 Reduced 5.93%	254 $0
Q3 2021 Oct 19, 2021	BUY	$1.69 - $2.89 $456 - $780	270 New	270 $1,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $117M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.